结节性硬化症合并膀胱瘤变1例并文献复习
Tuberous Sclerosis with Bladder Neoplasia in One Case and the Literature Review
DOI: 10.12677/ACM.2023.1351092, PDF,   
作者: 杨丛宁:青岛大学附属医院儿科神经内科,山东 青岛;威海市立医院儿科,山东 威海;张 颖*:青岛大学附属医院儿科神经内科,山东 青岛
关键词: 结节性硬化症膀胱瘤变肉眼血尿Tuberous Sclerosis Complex Bladder Neoplasia Gross Hematuria
摘要: 目的:探讨结节性硬化症(Tuberous sclerosis complex, TSC)合并膀胱瘤变的临床特点。方法:回顾性分析1例结节性硬化症合并膀胱瘤变患儿的临床资料,并进行文献复习。结果:男性患儿,11岁,首发症状为尿频、尿痛、肉眼血尿,尿常规可见隐血、无白细胞,泌尿系彩超结果为膀胱壁增厚并多发结节,未行膀胱结节活检,口服雷帕霉素治疗,目前暂无血尿。结论:TSC表现形式多样,需警惕多脏器病变可能。
Abstract: Objective: To explore the clinical features of tuberous sclerosis with bladder neoplasia. Methods: A retrospective analysis of the clinical data of a child with tuberous sclerosis complex with cystic neo-plasia and literature review. Results: An 11-year-old male child with initial symptoms of frequent urination, dysuria, gross hematuria, occult blood and no leukocytes in routine urine, urinary blad-der wall thickening and multiple nodules on color Doppler ultrasound, no bladder nodule biopsy, oral rapa Mycophenolate treatment, there is no hematuria at present. Conclusion: There are differ-ent forms of tuberous sclerosis complex, may need to alert to multiple organ lesions.
文章引用:杨丛宁, 张颖. 结节性硬化症合并膀胱瘤变1例并文献复习[J]. 临床医学进展, 2023, 13(5): 7816-7820. https://doi.org/10.12677/ACM.2023.1351092

参考文献

[1] Orlova, K.A. and Crino, P.B. (2010) The Tuberous Sclerosis Complex. Annals of the New York Academy of Sciences, 1184, 87-105. [Google Scholar] [CrossRef] [PubMed]
[2] Leung, A.K. and Robson, W.L. (2007) Tu-berous Sclerosis Complex: A Review. Journal of Pediatric Health Care, 21, 108-114. [Google Scholar] [CrossRef] [PubMed]
[3] Kalkan, M., Sahin, C., Etlik, O., et al. (2013) A Bladder Wall Angiomyolipoma as a Manifestation of Tuberous Sclerosis: First Case Report. Case Report in Urology, 2013, Article ID: 398328. [Google Scholar] [CrossRef] [PubMed]
[4] Tee, J.L., Chambers, J., et al. (2021) Bladder Perivascular Epi-thelioid Cell Tumour and Tuberous Sclerosis Complex: A Rare Association. BMJ Case Reports, 14, 1-4. [Google Scholar] [CrossRef] [PubMed]
[5] Schwartz, R.A., Femandez, G., Kotul Bka, K., et al. (2007) Tuber-ous Sclerosis Complex: Advances in Diagnosis, Genetics, and Management. Journal of the American Academy of Der-matology, 57, 189-202. [Google Scholar] [CrossRef] [PubMed]
[6] De Waele, L., Lagae, L. and Mekahli, D. (2015) Tuberous Sclerosis Complex: The Past and the Future. Pediatric Nephrology, 30, 1771-1780. [Google Scholar] [CrossRef] [PubMed]
[7] 李敏, 张继要, 董伟, 等. 结节性硬化症5家系临床及基因突变分析[J]. 临床儿科杂志, 2020(7): 541-544.
[8] 赵青青, 阮毅, 等. 结节性硬化症基因型与临床表型的关系[J]. 广西医学, 2021, 43(12): 1423-1426.
[9] Siroky, B.J., Towbin, A.J., Trout, A.T., et al. (2017) Improvement in Renal Cystic Disease of Tuberous Sclerosis Complex after Treatment with Mammalian Target of Rapamycin Inhibitor. The Journal of Pediatrics, 187, 318-322. https://linkinghub.elsevier.com/retrieve/pii/S0022347617306364 [Google Scholar] [CrossRef] [PubMed]
[10] Amin, S., Lux, A., Calder, N., et al. (2017) Causes of Mortality in Individuals with Tuberous Sclerosis Complex. Developmental Medicine & Child Neurology, 59, 612-617. [Google Scholar] [CrossRef] [PubMed]
[11] Manoukian, S.B. and Kowal, D.J. (2015) Comprehensive Imaging Mani-festations of Tuberous Sclerosis. American Journal of Roentgenology, 204, 933-943. [Google Scholar] [CrossRef